149 related articles for article (PubMed ID: 21366534)
41. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
42. Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.
Moraes GL; Gomes GC; Monteiro de Sousa PR; Alves CN; Govender T; Kruger HG; Maguire GE; Lamichhane G; Lameira J
Tuberculosis (Edinb); 2015 Mar; 95(2):95-111. PubMed ID: 25701501
[TBL] [Abstract][Full Text] [Related]
43. Cloning and expression of functional shikimate dehydrogenase (EC 1.1.1.25) from Mycobacterium tuberculosis H37Rv.
Magalhães ML; Pereira CP; Basso LA; Santos DS
Protein Expr Purif; 2002 Oct; 26(1):59-64. PubMed ID: 12356471
[TBL] [Abstract][Full Text] [Related]
44. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
Uddin R; Zahra NU; Azam SS
Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
[TBL] [Abstract][Full Text] [Related]
45. Studies of pyrimidine metabolism during chick development: enzymes involved in CMP breakdown.
Wegelin I
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 75(2):391-3. PubMed ID: 6138209
[TBL] [Abstract][Full Text] [Related]
46. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
Mohareer K; Asalla S; Banerjee S
Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
[TBL] [Abstract][Full Text] [Related]
47. Exploring Pyrimidine Pharmacophore as Thymidine Monophosphate Kinase Inhibitors for Antitubercular Activity: A Review.
Chitre TS; Asgaonkar KD; Patil SM; Kathiravan MK; Padhye SB
Curr Top Med Chem; 2016; 16(28):3211-3223. PubMed ID: 27150375
[TBL] [Abstract][Full Text] [Related]
48. Biochemical aspects of the selective antiherpes activity of nucleoside analogues.
De Clercq E
Biochem Pharmacol; 1984 Jul; 33(14):2159-69. PubMed ID: 6147138
[No Abstract] [Full Text] [Related]
49. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines.
Mulkins MA; Heidelberger C
Cancer Res; 1982 Mar; 42(3):965-73. PubMed ID: 7059992
[TBL] [Abstract][Full Text] [Related]
50. Hypoxanthine-guanine phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv: cloning, expression, and biochemical characterization.
Biazus G; Schneider CZ; Palma MS; Basso LA; Santos DS
Protein Expr Purif; 2009 Aug; 66(2):185-90. PubMed ID: 19362594
[TBL] [Abstract][Full Text] [Related]
51. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
[TBL] [Abstract][Full Text] [Related]
52. Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis.
Olaleye OA; Bishai WR; Liu JO
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S55-9. PubMed ID: 20006307
[TBL] [Abstract][Full Text] [Related]
53. Uridine monophosphate kinase as potential target for tuberculosis: from target to lead identification.
Arvind A; Jain V; Saravanan P; Mohan CG
Interdiscip Sci; 2013 Dec; 5(4):296-311. PubMed ID: 24402823
[TBL] [Abstract][Full Text] [Related]
54. [Purine and pyrimidine nucleoside phosphorylases - remarkable enzymes still not fully understood].
Bzowska A
Postepy Biochem; 2015; 61(3):260-73. PubMed ID: 26677573
[TBL] [Abstract][Full Text] [Related]
55. Biosynthesis and scavenging of pyrimidines by pathogenic mycobacteria.
Wheeler PR
J Gen Microbiol; 1990 Jan; 136(1):189-201. PubMed ID: 2191077
[TBL] [Abstract][Full Text] [Related]
56. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
57. Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase.
Breda A; Machado P; Rosado LA; Souto AA; Santos DS; Basso LA
Eur J Med Chem; 2012 Aug; 54():113-22. PubMed ID: 22608674
[TBL] [Abstract][Full Text] [Related]
58. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
[TBL] [Abstract][Full Text] [Related]
59. Pyrimidine metabolism in Tritrichomonas foetus.
Jarroll EL; Lindmark DG; Paolella P
J Parasitol; 1983 Oct; 69(5):846-9. PubMed ID: 6200591
[TBL] [Abstract][Full Text] [Related]
60. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches.
Bueno RV; Braga RC; Segretti ND; Ferreira EI; Trossini GH; Andrade CH
Curr Pharm Des; 2014; 20(27):4474-85. PubMed ID: 24245758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
